Emergent BioSolutions Reports Financial Results for First Quarter 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Emergent BioSolutions (EBS) PT Raised to $86 at Chardan Capital Markets
May 1, 2020 7:59 AM EDTChardan Capital Markets analyst Keay Nakae raised the price target on Emergent BioSolutions (NYSE: EBS) to $86.00 (from $71.00) while maintaining a Buy rating.
... MoreEmergent BioSolutions (EBS) Reports In-Line Q1 EPS
April 30, 2020 4:39 PM EDTEmergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $192.5 million versus the consensus estimate of $199.47 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
... More